According to the new market research report "Healthcare/Medical Simulation Market by Product and Service (Anatomical Models, Patient Simulators (High Fidelity, Low Fidelity), Task Trainer, Surgical Simulators, Software, Services), End User (Academic Institutes, Hospital) - Global Forecast to 2027", published by MarketsandMarkets™, is projected to reach USD 4.2 billion by 2027 from USD 1.9 billion in 2022, at a CAGR of 16.1% during the forecast period.
Download PDF Brochure:
CAE (Canada), Laerdal Medical (Norway), Simulab Corporation (US), Simulaids (US), Limbs Things (UK), Kyoto Kagaku (Japan), Mentice AB (Sweden), Gaumard Scientific Co. (US), Operative Experience Inc. (US), Cardionics Inc. (US) (a subsidiary of 3B Scientific), VirtaMed AG (Switzerland), SYNBONE AG (Switzerland), IngMar Medical (US), Medical-X (Netherlands), KaVo Dental GmbH (Germany), Altay Scientific (Italy), Simendo B.V. (Netherlands) VRMagic Holding AG (Germany), Symgery (Canada), HRV Simulation (France), Synaptive Medical (Canada), Inovus Medical (UK), TruCorp Ltd. (Ireland), and Surgical Science Sweden AG (Sweden)
Browse in-depth TOC on "Healthcare Simulation Market /Medical Simulation Market"
217 – Tables
41 – Figures
310 – Pages
Growth in this market is driven by the opportunities offered by the growing awareness about simulation training in emerging economies. However, high cost of simulators is expected to challenge the growth of this market to a certain extent.
Request Sample Pages:
The medical simulation anatomical models segment accounted for the largest share in the medical simulation industry, by product service
The healthcare simulation segment accounted for the largest market share of medical simulation market. Factors such as the increasing demand for primary care services, and the shortage of healthcare professionals are driving the growth of the segment.
By type, the laparoscopic surgical simulators segment registered the highest growth in the medical simulation industry, in 2021.
The laparoscopic surgical simulators segment is projected to register the highest growth in the medical simulation market. The high adoption of simulation techniques in laparoscopy and technological innovations are the key factors driving the growth of this segment.
North America dominated the medical simulation industry in 2021
North America accounted for the largest share of the medical simulation Industry in 2021, followed by Europe and Asia Pacific. The large share of North America in the global market can be attributed to the Accessibility to technologies, well-established distribution channels, and the rising number of healthcare professionals demanding hands-on patient training.
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies' revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets's flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
Mr. Aashish Mehra
630 Dundee Road
Northbrook, IL 60062
Point of Care Rapid Diagnostics Market is expected to reach USD 72.0 billion by 2027 from an estimated USD 43.2 billion in 2022, at a CAGR of 10.8% from 2022 to 2027
Lateral Flow Assays Market is projected to reach USD 12.6 billion by 2026 from USD 11.4 billion in 2021, at a CAGR of 2.0% during the forecast period.